荟萃分析
乳腺癌
优势比
医学
内科学
科学网
斯科普斯
肿瘤科
妇科
梅德林
癌症
生物
生物化学
作者
Mahdiyeh Harati‐Sadegh,Milad Mohammadoo-Khorasani,Saman Sargazi,Ramin Saravani,Sheida Shahraki,Ebrahim Eskandari
出处
期刊:Labmedicine
[Oxford University Press]
日期:2020-06-24
卷期号:52 (1): 36-46
被引量:8
标识
DOI:10.1093/labmed/lmaa055
摘要
Growing evidence suggests that IL-1β -511C>T, as a functional variant, affects the risk of developing breast cancer (BC); however, the results have not been conclusive. This meta-analysis was conducted to estimate the link between this variant and BC risk.We retrieved available publications on IL-1β -511C>T polymorphism by conducting a comprehensive literature search on the Web of Science, MEDLINE, PubMed, Scopus, and Google scholar databases (last search on February 25, 2020).The overall analysis indicates that IL-1β -511C>T polymorphism conferred an increased risk of BC under a recessive TT vs CT+CC model by 1.14-fold and showed protection against BC under an overdominant CT vs TT+CC genetic contrast model (odds ratio = 0.84). Stratified analysis based on ethnicity revealed the protective effect of this single-nucleotide polymorphism against BC risk in Caucasian patients.Our data results provide a proof of concept for the association of IL-1β -511C>T with BC risk. Larger, well-designed population-based studies are needed to confirm these findings.
科研通智能强力驱动
Strongly Powered by AbleSci AI